You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 17, 2025

Kenvue Brands Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for KENVUE BRANDS

KENVUE BRANDS has twenty-six approved drugs.



Summary for Kenvue Brands
US Patents:0
Tradenames:27
Ingredients:14
NDAs:26

Drugs and US Patents for Kenvue Brands

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Kenvue Brands PEPCID AC famotidine TABLET;ORAL 020325-002 Sep 23, 2003 OTC Yes Yes ⤷  Get Started Free ⤷  Get Started Free
Kenvue Brands JUNIOR STRENGTH MOTRIN ibuprofen TABLET;ORAL 020602-001 Jun 10, 1996 OTC No No ⤷  Get Started Free ⤷  Get Started Free
Kenvue Brands IMODIUM A-D loperamide hydrochloride TABLET;ORAL 019860-001 Nov 22, 1989 OTC Yes Yes ⤷  Get Started Free ⤷  Get Started Free
Kenvue Brands CHILDREN'S ZYRTEC ALLERGY cetirizine hydrochloride TABLET, CHEWABLE;ORAL 021621-004 Nov 16, 2007 OTC Yes No ⤷  Get Started Free ⤷  Get Started Free
Kenvue Brands MOTRIN MIGRAINE PAIN ibuprofen TABLET;ORAL 019012-004 Feb 25, 2000 DISCN No No ⤷  Get Started Free ⤷  Get Started Free
Kenvue Brands ZYRTEC HIVES cetirizine hydrochloride TABLET;ORAL 019835-006 Nov 16, 2007 DISCN Yes No ⤷  Get Started Free ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Kenvue Brands

Paragraph IV (Patent) Challenges for KENVUE BRANDS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Chewable Tablets 800 mg/ 10 mg/ 165 mg (OTC) ➤ Subscribe 2004-11-01
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Pharmaceutical Competitive Landscape Analysis: Kenvue Brands – Market Position, Strengths & Strategic Insights

Last updated: July 27, 2025


Introduction

Kenvue, a prominent player in the health and wellness sector, has emerged with a diverse portfolio rooted in iconic consumer healthcare brands. This analysis evaluates Kenvue’s market positioning, competitive strengths, and strategic trajectory within the pharmaceutical and consumer health landscapes. Given its integration of well-established brands, Kenvue’s strategic moves and competitive dynamics are vital for stakeholders seeking a comprehensive understanding of its influence and potential within this sector.


Kenvue’s Market Position

Kenvue operates predominantly within consumer health, encompassing segments such as skincare, oral care, baby care, and over-the-counter (OTC) medications. Its portfolio includes globally recognized brands like Johnson’s Baby, Tylenol, Neutrogena, and Listerine, positioning it as a household name across multiple wellness categories.

The company’s strategic emphasis on consumer-centric products aligns with growing demand for trusted, easily accessible health solutions. Its operational footprint spans North America, Europe, and emerging markets, giving it a broad distribution network and regional diversification that cushions against market-specific volatility.

In terms of revenue, Kenvue has demonstrated sustained growth driven by brand loyalty and expanding consumer preferences toward health and wellness products. Recent financial disclosures indicate resilience amidst global supply chain disruptions and shifting consumer behavior, reinforcing its market strength.

Competitive Strengths

1. Iconic Brand Portfolio
Kenvue’s assets include some of the world’s most recognizable healthcare brands. This extensive catalog offers a competitive moat, fostering brand loyalty and facilitating premium pricing strategies. For instance, Tylenol commands significant market share in OTC analgesics, benefiting from strong consumer trust rooted in decades of proven efficacy.

2. Distribution and Market Penetration
With established relationships with major retail chains, pharmacies, and online platforms, Kenvue ensures broad product availability. Its global distribution network allows rapid dissemination of innovative or new formulations, optimized for regional preferences.

3. Consumer Trust and Brand Equity
Long-standing history and proven safety profiles underpin consumer loyalty. Kenvue leverages this trust through targeted marketing campaigns and health education initiatives, maintaining high consumer engagement.

4. Innovation and Diversification
Kenvue invests considerably in product innovation, including natural/organic variants and formulations addressing modern health concerns. Its expansion into emerging markets is driven by adapting product offerings to local needs, fostering growth in less saturated markets.

5. Strategic Acquisition and Partnership Opportunities
The company maintains flexibility for acquisitions or licensing agreements, enhancing its portfolio with innovative products and expanding its pipeline. Strategic collaborations facilitate access to cutting-edge research, particularly in dermatology and oral care segments.

Market Challenges and Competitive Dynamics

Despite strengths, Kenvue faces challenges from fierce competition in OTC and consumer health sectors, with players like Johnson & Johnson (its predecessor’s origin), Procter & Gamble, Bayer, and GlaxoSmithKline intensifying rivalry. Rapid innovation cycles, patent expirations, and regulatory shifts contribute to an increasingly complex environment.

Competition also stems from burgeoning direct-to-consumer (DTC) brands and digital health startups leveraging e-commerce and telehealth channels. These entrants often offer niche, targeted products at competitive prices, eroding traditional market share.

Regulatory pressures, especially concerning claims and safety standards, necessitate ongoing compliance investments. Additionally, geopolitical tensions and supply chain disruptions continue to impact operational stability.

Strategic Insights and Recommendations

1. Focus on Digital Engagement and E-commerce
To counter the rise of DTC brands, Kenvue should amplify its digital marketing efforts, optimize e-commerce channels, and leverage data analytics for personalized marketing. Developing direct relationships with consumers through mobile apps or virtual health counseling can enhance loyalty and brand stickiness.

2. Accelerate Innovation with Consumer-Centric Solutions
Investing in R&D to develop clean-label, sustainable, and personalized products will meet evolving consumer preferences. Emphasizing ingredient transparency and health impact claims can differentiate Kenvue’s offerings.

3. Geographic Expansion in Emerging Markets
Targeted campaigns and localized formulations can capture market share in Asia-Pacific, Africa, and Latin America, where consumer health awareness is rising, yet market penetration remains comparatively low.

4. Strategic Mergers and Acquisitions
Acquiring niche brands or startups with innovative formulations can accelerate growth and diversify product lines. Collaborations with biotech firms and academic institutions could unlock new therapeutic and wellness innovations.

5. Sustainability and Corporate Responsibility
Implementing environmentally responsible manufacturing practices and transparent supply chains will resonate with eco-conscious consumers and investors alike, supporting long-term brand reputation.


Conclusion

Kenvue’s strong brand portfolio, consumer trust, and expansive distribution give it a resilient foothold in the competitive adult and pediatric healthcare sectors. However, it must continuously innovate and adapt to digital evolution, regional market nuances, and shifting consumer demands.

By leveraging its core strengths—brand equity, global reach, and innovation—while aligning with emerging health and sustainability trends, Kenvue can navigate the competitive landscape proactively. Strategic investments in digital channels, product development, and geographic expansion will be critical to maintaining its leading position.


Key Takeaways

  • Market positioning: Kenvue has a dominant presence in household healthcare through iconic brands, with strong regional and global distribution channels securing broad market access.
  • Strengths: A robust portfolio, high consumer trust, extensive distribution network, and ongoing product innovation underpin Kenvue’s competitive advantage.
  • Challenges: Intensified competition from both established players and emerging DTC brands, regulatory pressures, and supply chain disruptions require strategic agility.
  • Strategic opportunities: Embracing digital marketing, expanding into emerging markets, fostering product innovation aligned with consumer trends, and pursuing strategic acquisitions are key to future growth.
  • Long-term outlook: Sustained investment in innovation, sustainability, and consumer engagement will enable Kenvue to reinforce its market leadership amid evolving industry dynamics.

FAQs

1. How does Kenvue differentiate itself from competitors like Procter & Gamble or GSK?
Kenvue's differentiation lies in its extensive portfolio of iconic, trusted brands with deep consumer loyalty and established distribution channels. Its focus on long-term brand equity, combined with innovation and market expansion, distinguishes it from competitors that often emphasize product diversification or aggressive pricing strategies.

2. What is Kenvue’s growth strategy in emerging markets?
Kenvue targets emerging markets through localized product formulations, strategic partnerships, and expanding distribution networks. Tailoring brands to regional preferences and investing in consumer health education enhances market penetration.

3. How is digital transformation influencing Kenvue’s competitive position?
Digital channels enable Kenvue to engage consumers directly, gather data-driven insights, and personalize offerings. Implementing e-commerce strategies and health apps fosters brand loyalty and enhances consumer convenience.

4. What risks could threaten Kenvue’s market dominance?
Key risks include intensified competition, regulatory changes, supply chain disruptions, and shifts in consumer preferences towards alternative or new health solutions. Economic downturns may also impact consumer spending on healthcare products.

5. How can Kenvue leverage sustainability to strengthen brand equity?
By adopting eco-friendly manufacturing practices, transparent sourcing, and packaging innovations, Kenvue can appeal to environmentally conscious consumers and differentiate its brands, reinforcing long-term loyalty.


References

  1. [Kenvue Annual Report 2022]
  2. MarketWatch, "Global OTC Healthcare Market Analysis," 2022.
  3. Statista, "Consumer Healthcare Market Share by Company," 2023.
  4. McKinsey & Company, "The Future of Consumer Health," 2022.
  5. Deloitte, "Digital Transformation in Healthcare," 2023.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.